{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:16:39Z","timestamp":1790885799510,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ygyno.2021.06.020","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T04:37:02Z","timestamp":1624941422000},"page":"560-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples"],"prefix":"10.1016","volume":"162","author":[{"given":"Kimon","family":"Chatzistamatiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena","family":"Tsertanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Moysiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Mouchtaropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Pasentsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkmini","family":"Skenderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Agorastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.06.020_bb0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"USPSTF","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.ygyno.2021.06.020_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5694\/mja2.50223","article-title":"Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program","volume":"211","author":"Machalek","year":"2019","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0025","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2021.06.020_bb0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijc.30031","article-title":"Home-based HPV self-sampling improves participation by never-screened and under-screened women: results from a large randomized trial (iPap) in Australia","volume":"139","author":"Sultana","year":"2016","journal-title":"Int. J. Cancer J. Int. du Cancer."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12913-020-05214-5","article-title":"Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model","volume":"20","author":"Dutton","year":"2020","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0040","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ijc.30375","article-title":"A cohort study of cervical screening using partial HPV typing and cytology triage","volume":"139","author":"Schiffman","year":"2016","journal-title":"Int. J. Cancer J. Int. du Cancer."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0045","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00404-017-4324-x","article-title":"Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study","volume":"295","author":"Chatzistamatiou","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.ygyno.2021.06.020_bb0050","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ijc.31261","article-title":"Eurogin roadmap 2017: triage strategies for the management of HPV-positive women in cervical screening programs","volume":"143","author":"Cuschieri","year":"2018","journal-title":"Int. J. Cancer J. Int. du Cancer."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1158\/1940-6207.CAPR-19-0192","article-title":"Implementation of HPV-based cervical cancer screening combined with self-sampling using a midwifery network across rural Greece. The GRECOSELF study","volume":"12","author":"Agorastos","year":"2019","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0060","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1089\/jwh.2019.8258","article-title":"Acceptability of self-sampling for human papillomavirus-based cervical cancer screening","volume":"29","author":"Chatzistamatiou","year":"2020","journal-title":"J. Women\u2019s Health (Larchmt)"},{"key":"10.1016\/j.ygyno.2021.06.020_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000381842","article-title":"The pap test and Bethesda 2014. \u201cthe reports of my demise have been greatly exaggerated.\u201d (after a quotation from Mark Twain)","volume":"59","author":"Nayar","year":"2015","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0070","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"Jama."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0075","first-page":"1992","article-title":"The 2001 Bethesda system terminology","volume":"68","author":"Apgar","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ygyno.2021.06.020_bb0080","first-page":"31","article-title":"Semantic integration of cervical cancer data repositories to facilitate multicenter association studies: the ASSIST approach","volume":"8","author":"Agorastos","year":"2009","journal-title":"Cancer Informat."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e318254f90c","article-title":"2011 colposcopic terminology of the International Federation for cervical pathology and colposcopy","volume":"120","author":"Bornstein","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0100","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2468-2667(17)30007-5","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"Lew","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ygyno.2021.06.020_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Melnikow","year":"2018","journal-title":"Jama."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.23736\/S0026-4784.19.04468-X","article-title":"Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges","volume":"71","author":"Pimple","year":"2019","journal-title":"Minerva Ginecol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0120","first-page":"22","article-title":"Implementation of primary HPV testing in Japan","volume":"13","author":"Kurokawa","year":"2020","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0130","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/1055-9965.EPI-20-1177","article-title":"Assessing 10-year safety of a single negative HPV test for cervical cancer screening: evidence from FOCAL-DECADE cohort","volume":"30","author":"Gottschlich","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0140","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/1055-9965.EPI-18-0480","article-title":"Determinants for participation in human papillomavirus self-sampling among nonattenders to cervical cancer screening in Denmark","volume":"27","author":"Harder","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0145","doi-asserted-by":"crossref","first-page":"105931","DOI":"10.1016\/j.ypmed.2019.105931","article-title":"The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador","volume":"131","author":"Campos","year":"2020","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2021.06.020_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029158","article-title":"HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study","volume":"9","author":"Murchland","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ygyno.2021.06.020_bb0160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1186\/s12889-019-7292-1","article-title":"Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study","volume":"19","author":"Lorenzi","year":"2019","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.ygyno.2021.06.020_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1158\/1940-6207.CAPR-18-0419","article-title":"Participation in cervical screening by self-collection, Pap, or a choice of either in Brazil","volume":"12","author":"Castle","year":"2019","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cct.2017.11.004","article-title":"Rationale and design of the HOME trial: a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system","volume":"64","author":"Winer","year":"2018","journal-title":"Contemp. Clin. Trials."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0175","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2147\/CLEP.S164826","article-title":"HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups - a randomized controlled trial","volume":"10","author":"Tranberg","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0180","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3747\/co.25.3916","article-title":"Completing the cervical screening pathway: factors that facilitate the increase of self-collection uptake among under-screened and never-screened women, an Australian pilot study","volume":"25","author":"McLachlan","year":"2018","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2016.04.027","article-title":"Comparison of cytology, HPV DNA testing and HPV 16\/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening","volume":"142","author":"Chatzistamatiou","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119755","article-title":"Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology","volume":"10","author":"Agorastos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.06.020_bb0195","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.06.020_bb0205","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000381","article-title":"The interpretive variability of cervical biopsies and its relationship to HPV status","volume":"39","author":"Stoler","year":"2015","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:56:28Z","timestamp":1758772588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821005163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0090825821005163"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}